WS Audiology (WSA) has acquired IntoEars & Oogvoororen, a hearing care provider with 28 locations across the Netherlands and Belgium, further expanding the company’s direct retail presence in Europe. The transaction was completed through WSA Retail, the company’s retail division.
WSA is one of the world’s largest hearing healthcare companies and the parent company of hearing technology brands including Signia, Widex, Rexton, and Audio Service. The acquisition adds another regional hearing care network to WSA’s retail operations as major hearing healthcare companies continue investing in both technology development and clinical service delivery.
According to the companies, the acquisition is intended to strengthen access to high-quality hearing care while allowing the existing brands to continue operating under their established identities. IntoEars, Oogvoororen, and Oorwerk—already part of WSA Retail—will each retain their own names, teams, culture, and ways of working.
Under the new structure, Angelique De Wit, currently General Manager of Oorwerk, will also lead IntoEars & Oogvoororen. Existing director Herman Langstraat will gradually step back from day-to-day leadership, while former owners Joost Schravendeel and Yoeri Langstraat will remain involved to support continuity for employees, customers, and partners.
Company leaders said the organizations complement one another and share a focus on providing personalized hearing care and customized hearing solutions. The acquisition is expected to strengthen WSA’s position in the Netherlands and Belgium while expanding access to hearing care services in the region.
Part of a Broader Shift in Hearing Care
While the transaction is focused on the Netherlands and Belgium, it reflects a broader trend shaping the global hearing care industry: the continued expansion of large retail and vertically integrated hearing care networks.
Over the past decade, major hearing technology companies have increasingly invested not only in developing and manufacturing hearing devices, but also in building or acquiring direct-to-consumer hearing care channels. These networks allow companies to integrate hearing assessment, fitting, follow-up care, digital tools, and service delivery across a broader patient journey.
The trend toward consolidation accelerated this year with Amplifon’s announced acquisition of GN Hearing, the parent company of ReSound, Beltone, Interton, and other hearing brands. That transaction would combine one of the world’s largest hearing care retailers with a major hearing technology manufacturer, creating another vertically integrated global player.
Against that backdrop, WSA’s acquisition of IntoEars & Oogvoororen represents another example of how major hearing healthcare organizations are expanding their retail reach while investing in local clinical networks rather than simply distributing products through independent channels.
Local Brands, Larger Networks
A notable aspect of the acquisition is WSA’s decision to preserve the existing brands rather than consolidate them under a single identity. IntoEars & Oogvoororen will continue operating under their established names alongside Oorwerk while benefiting from the broader resources and expertise of WSA Retail.
This strategy reflects an increasingly common approach across the hearing care industry: maintaining the trust and reputation of local practices while leveraging larger organizations for operational support, technology adoption, training, purchasing power, and innovation.
For patients, the stated goal is continuity of care combined with greater access to personalized hearing solutions. For the industry, the acquisition underscores how hearing healthcare continues to evolve through consolidation, expanded retail networks, digital technologies, and new service delivery models designed to reach more people with hearing loss worldwide.
WSA’s latest acquisition further demonstrates that the future of hearing care is increasingly being shaped not only by innovation in hearing devices, but also by how those technologies are delivered to patients through integrated clinical networks.
Source: Hoorzaken
